Glipizide indications

Hyperglycemia in type 2 diabetes
Glipizide is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with type 2 diabetes formerly known as non-insulin-dependent diabetes mellitus (NIDDM) or maturity-onset diabetes, after an adequate trial of dietary therapy has proved unsatisfactory. Glipizide is indicated when diet alone has been unsuccessful in correcting hyperglycemia, but even after the introduction of the drug in the patient’s regimen, dietary measures should continue to be considered as important.